Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg/5ml and Nurofen®, Oral Suspension 100 mg/5 ml in Healthy Volunteers Under Fasting Conditions

计划入组 30 人 · 首次发布于 2018 年 6 月 19 日

Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions

计划入组 80 人 · 首次发布于 2018 年 10 月 15 日

The Effect of Financial Incentives on Utilization of Low-cost Providers

首次发布于 2014 年 9 月 25 日

RECKITT BENCKISER INC

United States

RECKITT BENCKISER LLC

United States

RECKITT BENCKISER HEALTHCARE (PHILIPPINES), INC.

Philippines

Reckitt's Mucinex 12HR Cold & Fever Multi-Symptom Receives FDA Approval as First OTC Cold & Flu Innovation in 14 Years

First Federal Bellwether Trial Opens Against Mead Johnson in NEC Infant Formula MDL

FDA Launches 'Operation Stork Speed' to Modernize Infant Formula Safety and Nutrition Standards